Auris Medical Holding AG (NasdaqGM:EARS) announced that it has received funding from new investor Kurma Biofund II, a fund managed by Kurma Partners on January 18, 2016.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -0.76% |
|
+4.80% | -62.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.36% | 37.12L | |
+20.17% | 13TCr | |
+24.67% | 12TCr | |
+23.73% | 2.79TCr | |
-17.74% | 2.1TCr | |
-15.68% | 1.69TCr | |
-15.21% | 1.62TCr | |
+11.91% | 1.48TCr | |
-47.10% | 1.48TCr | |
+54.50% | 1.41TCr |
- Stock Market
- Equities
- CYTO Stock
- News Altamira Therapeutics Ltd.
- Auris Medical Holding AG announced that it has received funding from Kurma Partners.